RecruitingNot ApplicableNCT03180827

Female Fertility Preservation Using Ovarian Tissue Cryopreservation Before Highly Gonadotoxic Cancer Treatment


Sponsor

Gumy-Pause Fabienne

Enrollment

100 participants

Start Date

Jun 1, 2015

Study Type

INTERVENTIONAL

Conditions

Summary

Background: Due to the remarkable improvement in treatments these last decades, long term survival can be expected in more than 80% of childhood cancer patients. Unfortunately, cancer treatments can be harmful to the gonads and can affect reproductive and endocrine functions. While loss of fertility is a major concern for most patients, only the experimental option of ovarian tissue cryopreservation can be proposed to prepubertal girls with a high risk of infertility. For pubertal patient, cryopreservation of mature oocytes after ovarian stimulation can be offered if oncological treatment debut can be delayed. As it is often not possible, ovarian tissue cryopreservation can also be offered. Primary aims \- To cryopreserve ovarian tissue of pre or peripubertal patient who will be receiving highly gonadotoxic oncological treatment. Secondary aims * To create a database in order to record clinical and biological follow-up data * To pool resources with Fertisave Registry * To create a research biobank for future research projects Multicentric study: HUG, CHUV


Eligibility

Sex: FEMALEMin Age: 2 MonthsMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is preserving the future fertility of young girls and female children who are about to undergo cancer treatments that are likely to damage their ovaries, by surgically removing and freezing ovarian tissue so it can potentially be transplanted back later in life. **You may be eligible if...** - The patient is a female child aged 2 months or older (including pre-pubescent and peri-pubertal patients) - She is about to receive cancer treatments with a high risk of causing infertility, such as high-dose chemotherapy with alkylating agents, radiation to the ovaries, or total body radiation - A multidisciplinary medical team has recommended this procedure **You may NOT be eligible if...** - The patient is under 2 months old - The patient or her parents refuse the procedure - The planned treatments are not classified as highly toxic to the reproductive system Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREovarian tissue biopsy

ovarian tissue biopsy during general anesthesia


Locations(2)

Geneva University Hospitals

Geneva, Switzerland

CHUV

Lausanne, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03180827


Related Trials